Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: Systemic, Mucosal & Passive Immunity |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-08-21 |
| Study Made Public: | 2014-01-09 |
Title
Passive Humoral Immunity and Sterilizing Protection- To determine whether passive immunization with monoclonal antibodies specific for unique epitopes on gp120-CD4 immunogens can afford sterilizing protection against a rectal challenge with a model AIDS vaccine
Description
CAVD 422 is a non-human primate challenge study comparing passive immunization regimens using broadly neutralizing monoclonal antibodies.
Sign in to see full information about this study and to download study data.
Products
SHIV162p3 N60-B1.1 N12-i2 N12-i2 LALA N60-B1.1 LALA IgG B12 NoneIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.